SEPTInvestingStart Free
Stocks/GRDN/SEC Filings/SCHEDULE 13D/A Sep 28, 2026

GRDN SCHEDULE 13D/A: SEC filing

A group of reporting persons

Filed with the SEC on Sep 28, 2026 · accession 0001193125-26-405492

GRDN filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Sep 28, 2026. A group of reporting persons filed Amendment No. 4 to their Schedule 13D, disclosing collective beneficial ownership of 27,822,550 shares of Guardian Pharmacy Services Class A common stock, representing approximately 43.9% of the outstanding shares. The stock moved -1.1% by the first close after the filing.

Summary of the filing

A group of reporting persons filed Amendment No. 4 to their Schedule 13D, disclosing collective beneficial ownership of 27,822,550 shares of Guardian Pharmacy Services Class A common stock, representing approximately 43.9% of the outstanding shares. The filing also notes that 13,521,396 shares of Class A common stock were issued upon automatic conversion of Class B common stock on September 27, 2026.

For details, click here →

Key details

Collective beneficial ownership of Class A common stock by reporting persons$27.8M
Shares of Class A common stock outstanding$63.3M
Shares issued upon automatic conversion of Class B common stock$13.5M
IssuerGuardian Pharmacy Services, Inc.
Reporting personBindley Capital Partners I, LLC
Reporting personPharmacy Investors, LLC
Reporting personCardinal Equity Fund, L.P.
Member and officer of bindley capital partners, llcWilliam E. Bindley
Member and officer of bindley capital partners, llcThomas J. Salentine, Jr.
Manager of pharmacy investors, llcJohn Ackerman
Reporting personFred P. Burke
Reporting personDavid K. Morris
Reporting personG. Kendall Forbes

How GRDN stock reacted

Close before

$41.21

Sep 25, 2026

First close after

-1.14%

$40.74

5 trading days

+2.84%

$42.38

Since filing

+2.86%

$42.39

✦ Ask GOAX AI about this filing — what it means for GRDN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GRDN?

Click here

Frequently asked questions

What did GRDN file with the SEC on Sep 28, 2026?

GRDN filed a SCHEDULE 13D/A (SEC filing). A group of reporting persons filed Amendment No. 4 to their Schedule 13D, disclosing collective beneficial ownership of 27,822,550 shares of Guardian Pharmacy Services Class A common stock, representing approximately 43.9% of the outstanding shares. The filing also notes that 13,521,396 shares of Class A common stock were issued upon automatic conversion of Class B common stock on September 27, 2026.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did GRDN stock react to this filing?

GRDN closed at $41.21 before the filing and $40.74 on Sep 28, 2026 (-1.14%). Five trading days later: $42.38 (+2.84%).

Other GRDN SEC filings

  • SCHEDULE 13G/A · SEC filingNov 5, 2026
  • 10-Q · SEC filingNov 5, 2026
  • 8-K · SEC filingNov 5, 2026
  • 8-K · SEC filingSep 10, 2026
  • 10-Q · SEC filingAug 6, 2026
  • 8-K · SEC filingAug 6, 2026
  • 8-K · Executive departureJun 22, 2026
  • 8-K · Material agreementMay 28, 2026
  • 8-K · Board changeMay 7, 2026
  • 10-Q · SEC filingMay 6, 2026

Get alerts when GRDN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
GRDN overviewGRDN analysisGRDN newsLatest SEC filings
Source: SEC EDGAR filing 0001193125-26-405492. The summary and key details are extracted by SEPT from the filing and may contain errors. Price reaction uses daily closing prices. Not financial advice.